Blog

New Central Virginia campus expands EdgeCore’s Virginia data center portfolio to over 1.6GW

DENVER, CO / ACCESS Newswire / June 25, 2025 / EdgeCore Digital Infrastructure, a wholesale data center developer, owner, and operator, announced the purchase of 697 acres of land in the Shannon Hill Regional Business Park in Louisa County, Virginia, and plans to develop a 3.9 million square foot high-density data center campus capable of supporting over 1.1 gigawatts of power.

“EdgeCore was deliberate and intentional in our decision to commit to Louisa County for the development of a 1.1+ GW high-density data center campus,” said Lee Kestler, CEO, EdgeCore Digital Infrastructure. “The investment in this land enables EdgeCore to expand our growth in Central Virgina, providing our hyperscale and AI focused customers with scalable, cost-efficient data center solutions, while simultaneously benefitting the residents of Louisa County with decades of tax revenue, job creation and ancillary investments. I want to thank the Louisa County Industrial Development Authority and the Commonwealth’s economic development team for their support.”

“Virginia is the world capital for the infrastructure on which the internet and the entire global economy runs. From the spine of the internet running through Ashburn to the transatlantic cables that connect in Virginia Beach, the entire Commonwealth is engaged in supporting the technology which runs the world. We are proud to welcome EdgeCore to Central Virginia where their $17 billion investment will create jobs and fund vital public resources,” said Governor Glenn Youngkin.

“REC and our affiliate, Hyperscale Energy, are proud to support EdgeCore’s significant investment in Louisa County. Their vision aligns with the growing demands of the digital economy, and we’re honored they chose our service area for this major development,” said John Hewa, CEO, Rappahannock Electric Cooperative. “As a cooperative committed to delivering world-class service to our data center members, we look forward to working alongside EdgeCore and Louisa County to power this project and build the infrastructure that enables its success.”

As EdgeCore has done with its data center campuses in other markets, the company will employ its community-first approach in Louisa County. Residents can expect EdgeCore’s development to generate economic growth and jobs, as well as to have minimal impact on local water supplies and the surrounding Central Virginia landscape. EdgeCore will leverage best practices honed in Greater Phoenix and other markets to minimize traffic during construction, and respond quickly to questions raised by community members.

“In my role as EdgeCore’s head of community and government relations, I lean heavily on my 25 years of experience in economic development to ensure that the communities in which we do business see EdgeCore as a resource and a partner,” said William Jabjiniak, SVP, National Community/Government Relations, EdgeCore Digital Infrastructure. “In Louisa County, we intend to contribute as a good neighbor would by investing our time and resources to the betterment of the county at large.”

To ensure EdgeCore’s campus makes the most efficient use of water possible, the company will employ a close-looped air-cooled system at its Louisa County campus that uses very little water to cool its facilities, carrying a benchmark water usage effectiveness (WUE) rating below .01 L/kWh.

Today’s new market announcement about Louisa County brings EdgeCore’s total active market count to six, including Ashburn, Culpeper, VA, Silicon Valley, Greater Phoenix and Reno, all of which have been designed to accommodate data centers for single hyperscale tenants.

About EdgeCore Digital Infrastructure

EdgeCore Digital Infrastructure serves the world’s largest cloud and internet companies with both ready-for-occupancy and build-to-suit data center campuses that are designed for density. Privately held and backed by committed equity, EdgeCore enables hyperscale customer requirements by proactively investing in regions that provide the land and power necessary to support and scale AI and cloud technology. While working thoughtfully with the communities in which we do business, our data center campuses are built at scale to meet key performance specifications, safety metrics and sustainability objectives. EdgeCore has data center campuses in six North American markets with plans to continue regional expansion in 2025 and beyond. For more information, please visit edgecore.com.

Media Contact
Courtney Gaudet
EdgeCore Digital Infrastructure
courtney.gaudet@edgecore.com

SOURCE: EdgeCore Digital Infrastructure

View the original press release on ACCESS Newswire

Reverse Split Becomes Effective Friday, June 27, 2025

Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements

AUSTIN, TEXAS / ACCESS Newswire / June 25, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or “the Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective on June 27, 2025, and the Company’s common stock will begin trading on a post-split basis at the market open on June 27, 2025, under the Company’s existing trading symbol “TRNR”, with the new CUSIP number, 45840Y401. The reverse stock split is part of the Company’s plan to maintain compliance with the minimum bid price requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.

The reverse stock split range was approved by the Company’s stockholders at the Company’s Special Meeting of Stockholders held on March 11, 2025, at the discretion of the Company’s Board of Directors. The final ratio was approved by the Company’s Board on May 6, 2025.

The reverse stock split is expected to reduce the number of shares of the Company’s outstanding common stock to approximately 1.4 million shares from approximately 13.9 million shares. As a result of the reverse stock split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding preferred stock, equity awards and warrants and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the conversion or exercise price, as applicable. There will be no change to the number of authorized shares or the par value per share of the Company’s common stock.

Information for TRNR Stockholders

As a result of the reverse stock split, every ten pre-split shares of common stock outstanding will become one share of common stock. The Company’s transfer agent, Equiniti Trust Company, LLC, will serve as the exchange agent for the reverse stock split.

Registered stockholders holding pre-split shares of the Company’s common stock electronically in book-entry form are not required to take any action to receive post-split shares. Those stockholders who hold their shares in brokerage accounts or in “street name” will have their positions automatically adjusted to reflect the reverse stock split, subject to each broker’s particular processes, and will not be required to take any action in connection with the reverse stock split.

Stockholders holding shares of the Company’s common stock in certificate form will have their holdings of the Company’s common stock automatically adjusted to reflect the reverse stock split.

No fractional shares will be issued in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares will receive cash for each fraction of a share they hold.

TRNR Investor Contact

ir@interactivestrength.com

About Interactive Strength Inc.:

Interactive Strength Inc. produces innovative specialty fitness equipment and digital fitness services under two main brands: 1) CLMBR and 2) FORME. Interactive Strength Inc. is listed on Nasdaq (symbol:TRNR).

CLMBR is a vertical climbing machine that offers an efficient and effective full-body strength and cardio workout. CLMBR’s design is compact and easy to move – making it perfect for commercial or in-home use. With its low impact and ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy facilities, as well as available for consumers at home. www.clmbr.com.

FORME is a digital fitness platform that combines premium smart gyms with live virtual personal training and coaching to deliver an immersive experience and better outcomes for both consumers and trainers. FORME delivers an immersive and dynamic fitness experience through two connected hardware products: 1) The FORME Studio Lift (fitness mirror and cable-based digital resistance) and 2) The FORME Studio (fitness mirror). In addition to the company’s connected fitness hardware products, FORME offers expert personal training and health coaching in different formats and price points through Video On-Demand, Custom Training, and Live 1:1 virtual personal training. www.formelife.com.

Forward Looking Statements:

This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: our ability to regain compliance with Nasdaq’s continued listing requirements; market and other conditions; demand for our products; competition, including technological advances made by and new products released by our competitors; our ability to accurately forecast consumer demand for our products and adequately maintain our inventory; and our reliance on a limited number of suppliers and distributors for our products. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

# # #

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.

This expansion reflects Wellgistics’ accelerating momentum in creating a modern drug ecosystem-one that aims to connect manufacturers directly to pharmacies, providers, employers, and patients through a fully integrated, AI-powered infrastructure designed to streamline fulfillment, reduce costs, and bypass legacy bottlenecks.

“We’re in hyper structural transformation mode,” said Brian Norton, CEO of Wellgistics Health. “Pharma companies are signaling a shift. They want partners who can deliver speed, visibility, and direct access-not more layers of complexity. Every new manufacturer, every new product, and every new pharmacy is helping us rewire how prescriptions move in this country. We’re laying the foundation for real-time, patient-first drug access at national scale.”

As Wellgistics continues to advance toward direct-to-patient care programs, the company intends to leverage its expanding distribution, fulfillment, and pharmacy network to support new models of care-aligning pharmaceutical manufacturers with a streamlined path to market while offering patients faster, more transparent prescription access.

The Wellgistics platform spans the full prescription journey-from wholesale distribution and digital Rx routing to pharmacy dispensing and Hub Services including eligibility, prior authorization, adherence tracking, and patient engagement. With thousands of pharmacies on board and manufacturer demand accelerating, Wellgistics seeks to be a vital infrastructure partner for reshaping prescription drug delivery in the U.S.

About Wellgistics Health

Wellgistics Health (NASDAQ:WGRX) is a healthcare technology company built for the $500B prescription drug market. Our AI-powered, vertically integrated platform connects pharmaceutical manufacturers directly to providers, pharmacies, employers, and patients-managing the full journey from maker to taker. From distribution and digital routing to pharmacy fulfillment and Hub Services, Wellgistics is delivering the infrastructure to power a faster, smarter, and more transparent future in prescription access.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health’s statements regarding Wellgistics Health’s strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health’s filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com

Investor Relations Contact:

Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / June 25, 2025 / Electrovaya Inc. (“Electrovaya” or the “Company”) (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company, today announced that Dr. Raj DasGupta, Electrovaya’s CEO will be participating at the Roth 15th Annual-London Conference, held at the Four Seasons Park Lane in London, UK.

The Company’s participation underscores Electrovaya’s ongoing commitment to active engagement with the global financial community. During the conference, CEO, Raj DasGupta will take part in one-on-one and small group meetings with leading European institutional investors to discuss the Company’s strategic initiatives, technology roadmap, and long-term growth outlook.

Event: ROTH – 15th Annual – London Conference
Date: June 25-26, 2025
Location: Four Seasons Park Lane, London, UK
Format: 1×1 small group meetings – by invitation only

For more information on the ROTH – 15th Annual – London, UK Conference, or to schedule a one-on-one meeting with Electrovaya’s management, please contact your ROTH representative.

Investor and Media Contact:
Jason Roy
VP, Corporate Development and Investor Relations
Electrovaya Inc.
905-855-4618 / jroy@electrovaya.com

About Electrovaya Inc.
Electrovaya Inc. (NASDAQ:ELVA)(TSX:ELVA) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries. The Company has extensive IP and designs, develops and manufactures proprietary lithium-ion batteries and battery systems for energy storage and heavy duty electric vehicles based on its Infinity Battery Technology Platform. This technology offers enhanced safety and industry leading battery longevity. The Company is also developing next generation solid state battery technology at its Labs division. Headquartered in Ontario, Canada, Electrovaya has two operating sites in Canada and has acquired a 52-acre site with a 135,000 square foot manufacturing facility in New York state for its planned gigafactory. To learn more about Electrovaya, please explore www.electrovaya.com.

SOURCE: Electrovaya, Inc.

View the original press release on ACCESS Newswire

Advancement of long lead work programs to support ML Application

HIGHLIGHTS

• Recent Tunkillia OSS confirms large-scale gold project yielding $2.7bn operating cash^[1]

• Barton accelerating key long-lead PFS and Mining Lease Application programs

ADELAIDE, AUSTRALIA / ACCESS Newswire / June 24, 2025 / Barton Gold Holdings Limited (ASX:BGD)(FRA:BGD3)(OTCQB:BGDFF) (Barton or Company) is pleased to announce the start of baseline water monitoring programs for its South Australian Tunkillia Gold Project (Tunkillia), following the recent publication of Tunkillia’s Optimised Scoping Study (OSS).

The Tunkillia OSS identified a compelling large-scale operation with (at an A$5,000/oz gold price): ¹

• average annual production: ~120koz gold and ~250koz silver

• operating free cashflow: A$2.7 billion

• Net Present Value (NPV _7.5% ): A$1.4 billion

• Internal Rate of Return (IRR): 73%

• Payback period: 0.8 years, and

• A ‘Starter’ pit producing ~206koz Au for A$825m operating free cash in the first 13 months

Barton recently announced a $3 million equity accretive placement priced at a ~4% premium to its last traded price, and a ~25% premium to its 20 trading day volume weighted average price (VWAP).^[2] The use of those funds is primarily to accelerate Reserve conversation upgrade drilling for Tunkillia’s ‘Starter Pit. ² Drilling is anticipated to commence during September 2025, and complete by December 2025.

The baseline water monitoring program is another key long-lead feasibility and approvals work program, with a minimum of two years’ worth of baseline water data required prior to start of mining and production. The new Tunkillia water monitoring program will allow Barton to compare new baseline data with historical baseline data collected during prior analyses of the Tunkillia Gold Project.

Commenting on the start of Tunkillia water monitoring, Barton MD Alexander Scanlon said:

“Tunkillia’s Optimised Scoping Study has confirmed a large-scale, competitive gold and silver operation with significant economies of scale offering strong financial and capital leverage to a rapidly evolving gold market.

“During the balance of calendar year 2025 we will focus on key long-lead feasibility and approvals programs for Tunkillia, with the objective to submit a Mining Lease Application prior to the end of calendar year 2026.

“In parallel, we will be completing our studies for ‘Stage 1′ operations leveraging our Central Gawler Mill, with the objective to transition to ‘producer’ status during 2026. This will enable us to generate free cash flows, and use these funds to advance and develop Tunkillia as our ‘Stage 2′ expansion project. This staged approach offers our shareholders a lower-cost, lower-risk and lower-dilution pathway to 150,000ozpa gold production.”

Authorised by the Managing Director of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon Managing Director a.scanlon@bartongold.com.au +61 425 226 649

Jade Cook Company Secretary cosec@bartongold.com.au +61 8 9322 1587

SOURCE: Barton Gold Holdings Limited

View the original press release on ACCESS Newswire

BOCA RATON, FL / ACCESS Newswire / June 24, 2025 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane”), a global seller of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that it will effect a one-for-seven hundred fifty reverse stock split (the “Reverse Split”) of its Class A common stock, par value $0.01 per share (the “Class A common stock”), that will become effective on June 26, 2025 at 5:00 P.M. Eastern Time, after the closing of trading on The Nasdaq Capital Market (“Nasdaq”). Greenlane has requested that Greenlane’s Class A common stock begin trading on June 27, 2025, on a post-Reverse Split basis on the Nasdaq under the existing symbol “GNLN.”

The Reverse Split is primarily intended to bring Greenlane into compliance with the minimum bid price requirement for maintaining its listing on the Nasdaq. The new CUSIP number for the Class A common stock following the Reverse Split will be 395330509.

At Greenlane’s special meeting of stockholders on June 16, 2025 (the “Special Meeting”), Greenlane’s stockholders approved the proposal to authorize Greenlane’s board of directors (the “Board”), in its sole and absolute discretion, to file a certificate of amendment (the “Amendment”) to Greenlane’s amended and restated certificate of incorporation to effect the Reverse Split at a ratio to be determined by the Board, ranging from one-for-two hundred fifty to one-for-seven hundred fifty. On June 12, 2025, the Board approved the Reverse Split at a ratio of one-for-seven hundred fifty and the Amendment has been filed with the Secretary of State of the State of Delaware, which will become effective on June 26, 2025, at 5:00 P.M. Eastern Time, before the opening of trading on the Nasdaq.

The Reverse Split will affect all issued and outstanding shares of Class A common Stock. All outstanding options, restricted stock awards, warrants and other securities entitling their holders to purchase or otherwise receive shares of Class A common stock will be adjusted as a result of the Reverse Split, as required by the terms of each security. The number of shares available to be awarded under Greenlane’s Third Amended and Restated 2019 Equity Incentive Plan, will also be appropriately adjusted. Following the Reverse Split, the par value of the Class A common stock will remain unchanged at $0.01 per share. The Reverse Split will not change the authorized number of shares of Class A common stock or preferred stock. No fractional shares of Class A Common Stock shall be issued as a result of the Reverse Split, and stockholders who otherwise would be entitled to receive fractional shares of New Class A Common Stock shall be entitled to receive the number of shares of New Class A Common Stock rounded up to the next whole number. The Reverse Split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in Greenlane’s equity (other than as a result of the rounding of fractional shares, as set forth above).

The Reverse Split will reduce the number of shares of Class A common stock issued and outstanding from approximately 1,039,735,642 million to approximately 1,386,314.

About Greenlane Holdings, Inc.

Founded in 2005, Greenlane is a premier global platform for the development and distribution of premium smoking accessories, vape devices, and lifestyle products to thousands of producers, processors, specialty retailers, smoke shops, convenience stores, and retail consumers. We operate as a powerful family of brands, third-party brand accelerator, and an omnichannel distribution platform.

We proudly offer our own diverse brand portfolio including Higher Standards and Groove, and our exclusively licensed Marley Natural and K.Haring branded products. We also offer a carefully curated set of third-party products such as DaVinci Vaporizers, Storz & Bickel, Eyce, Pax, VIBES, and CCELL through our direct sales channels and our proprietary, owned and operated e-commerce platforms which include Vapor.com, PuffItUp.com, HigherStandards.com, and MarleyNaturalShop.com.

For additional information, please visit: https://investor.gnln.com.

Forward Looking Statements

Certain matters within this press release are discussed using forward-looking language as specified in the Private Securities Litigation Reform Act of 1995, and, as such, may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These forward-looking statements include, among others, statements relating to: the current and future performance of the Company’s business, the Company’s ability to satisfy the various rules and requirements imposed by The Nasdaq Stock Market, unforeseen technical issues that could result in Greenlane’s Class A common stock not trading on The Nasdaq Stock Market on a post-Reverse Stock split basis on June 27, 2025 as expected and the Company’s financial outlook and expectations. For a description of factors that may cause the Company’s actual results or performance to differ from its forward-looking statements, please review the information under the heading “Risk Factors” included in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2024, the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, and the Company’s other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to Greenlane on the date hereof. Greenlane undertakes no duty to update this information unless required by law.

Investor Contact:

IR@greenlane.com

or

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Greenlane Holdings, Inc.

View the original press release on ACCESS Newswire

Company’s CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing

SAN FRANCISCO, CA / ACCESS Newswire / June 24, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or “the Company”), announced today that the maturity date has been extended from June 30, 2025 to January 30, 2026 for approximately $2.57 million aggregate principal amount of convertible promissory notes originally issued by the Company as part of the previously announced $3.448 million bridge financing that closed on March 31, 2025. Prior to the extension, five investors converted $0.866 million (including accrued interest) of the original bridge financing into equity in the Company.

“We’re very pleased with each of the participants in this bridge financing that agreed to the extension of the maturity date,” said Lisa Conte, Jaguar’s Founder and CEO. “Each of these investors is committed to helping provide the resources needed to support Jaguar’s goal of forging corporate partnerships to bring in non-dilutive funding for the Company’s three core development programs for crofelemer, our novel plant-based prescription medicine: our orphan disease intestinal failure program; our ongoing efforts to make crofelemer available for treatment of cancer therapy-related diarrhea (CTD) in patients with metastatic breast cancer receiving selected targeted therapies; and our ongoing development program to expand access for Canalevia^® (crofelemer delayed-release tablets) in dogs from the conditional approval in chemotherapy-induced diarrhea to a potential global approval for acute general diarrhea.”

To view the original terms of the bridge financing, as announced on March 26, 2025, please click here. To view the terms of the extension, please refer to the Form 8-K filed by the Company today, June 24, 2025, which can be viewed on the SEC Filings page of Jaguar’s website. Click here to access the SEC Filings page of Jaguar’s website.

About the Jaguar Health Family of Companies

Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo’s crofelemer is FDA-approved under the brand name Mytesi^® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:

Jaguar Health, visit https://jaguar.health

Napo Pharmaceuticals, visit www.napopharma.com

Napo Therapeutics, visit napotherapeutics.com

Magdalena Biosciences, visit magdalenabiosciences.com

Canalevia-CA1, visit canalevia.com

Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s goal of forging corporate partnerships to bring in non-dilutive funding for the Company’s three core development programs for crofelemer: the Company’s orphan disease intestinal failure program; the Company’s ongoing efforts to make crofelemer available for treatment of CTD in patients with metastatic breast cancer receiving selected targeted therapies; and the Company’s ongoing development program to expand access for Canalevia in dogs from the conditional approval in chemotherapy-induced diarrhea to a potential global approval for acute general diarrhea.In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

hello@jaguar.health

Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

View the original press release on ACCESS Newswire

SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 24, 2025 / General Atomics Electromagnetic Systems (GA-EMS) announced today that it has reached another significant milestone in the development and testing of its SiGA^® Silicon Carbide (SiC) nuclear fuel cladding technology. Recent performance testing on GA-EMS’ patented, localized SiC joining method has shown excellent performance under the corrosive water conditions expected in the current fleet of pressurized water nuclear reactors, marking a significant step in advancing the readiness of SiGA cladding for reactor testing. SiGA is an engineered, multilayer composite cladding structure that offers high temperature performance and other operational benefits for current and future nuclear reactors.

“Our patented local joining process seals the fuel rods without exposing the nuclear fuel pellets to high temperature water,” said Scott Forney, president of GA-EMS. “Our SiC cladding and localized joining method form a complete solution to fully and safely contain the solid fuel and enable it to withstand temperatures six times greater than the expected light-water, pressurized water reactor conditions. The local SiC joining process is also proving to reduce processing time, supporting the scale-up of efficient domestic manufacturing capability to provide safe accident tolerant fuel cladding for the nuclear fleet.”

Fuel cladding is a barrier between the reactor coolant and nuclear fuel pellets and is essential to protecting the fuel while also ensuring the safety of a nuclear power plant. Fuel is stacked into cladding tubes and the ends of the tubes are joined to form hermetic seals for the fuel rods. GA-EMS’ SiGA cladding offers superior high temperature and irradiation resistance which can significantly improve the operating performance, economic efficiency, and safety of light water reactors.

“We’ve successfully verified irradiation resistance of our ceramic joints at the Oak Ridge National Laboratory High Flux Isotope Reactor test reactor,” said Dr. Christina Back, vice president of GA-EMS Nuclear Technologies and Materials. “Now, GA-EMS is working to evaluate the quality of the SiGA joints under the high temperature, high pressure, and corrosive water coolant environment expected in pressurized water reactors. We achieved a critical milestone this past month, with results confirming that joints fabricated by our local SiC joining process remained gas-tight after 180-days of exposure in Westinghouse’s reactor coolant test facility. It is very exciting to be moving to the ultimate demonstration of joint performance testing in the Advanced Test Reactor at Idaho National Laboratory in the presence of both corrosive water coolant and neutron irradiation.”

Acknowledgment: Based upon work supported by the US Department of Energy under Award No. DE-NE0009235 “SiC Cladding Development.”

Contact Information
General Atomics Electromagnetic Systems Media Relations
ems-mediarelations@ga.com
8589646989

SOURCE: General Atomics Electromagnetic Systems

View the original press release on ACCESS Newswire

SAN BERNARDINO, CA / ACCESS Newswire / June 24, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF), a leading Australian mining and exploration company, today announced that its Managing Director, Stephen Baghdadi, has invested over $1.06 million in the company by exercising 53,000,208 share options. This significant capital injection underscores Baghdadi’s confidence in Dateline’s strategic direction and its flagship Colosseum Gold and Rare Earth Elements (REE) Project in California.

Baghdadi’s investment increases his shareholding to 396,890,307 shares, representing 12.85% of the company, further aligning his interests with those of shareholders. The $1.06 million cash injection bolsters Dateline’s financial position, bringing total cash and option exercise commitments to nearly $9 million. “Exercising these options was an easy decision because I have great confidence in Dateline’s long-term future. Our project is a high-quality asset with tremendous upside. Increasing my stake in the Company is a long-term investment for me and it underscores my commitment to our long-term vision and growth, and it enhances the company finances by bringing the total cash at bank and option exercise commitments to almost $9,000,000,” said Baghdadi.

The funds will support ongoing exploration and development at the Colosseum Project, located in California’s Walker Lane Trend. A past-producing gold mine, Colosseum has a JORC-2012 compliant Mineral Resource estimate of 27.1 million tonnes at 1.26 g/t gold for 1.1 million ounces, as announced on June 6, 2024. Recent exploration has revealed promising REE mineralization, positioning Colosseum as a unique dual-commodity opportunity. On May 23, 2025, Dateline reported updated economics for the project, projecting an NPV6.5 of $550 million and an IRR of 61% at a gold price of $2,900 per ounce. The project’s proximity to the Mountain Pass Rare Earth mine, less than 10 kilometers away, enhances its potential in the growing critical minerals market.

Dateline’s Board of Directors welcomed Baghdadi’s investment as a strong endorsement of the company’s strategy. “Stephen’s commitment reinforces our confidence in the Colosseum Project’s ability to deliver long-term value for shareholders,” the Board stated. The capital will advance drill testing to assess the project’s REE potential and further unlock its gold resources.

About Dateline Resources Limited

Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) is an Australian company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.

The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.

On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.

The Colosseum is located less than 10km north of the Mountain Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.

Forward-Looking Statements

This announcement may contain “forward-looking statements” concerning Dateline Resources that are subject to risks and uncertainties. Generally, the words “will”, “may”, “should”, “continue”, “believes”, “expects”, “intends”, “anticipates” or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Dateline Resources’ ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behavior of other market participants. Dateline Resources cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements. Dateline Resources assumes no obligation and does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

Competent Person Statement

Sample preparation and any exploration information in this announcement is based upon work reviewed by Mr Greg Hall who is a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM). Mr Hall has sufficient experience that is relevant to the style of mineralization and type of deposit under consideration and to the activity which he is undertaking to quality as a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves” (JORC Code). Mr Hall is a Non-Executive Director of Dateline Resources Limited and consents to the inclusion in the report of the matters based on this information in the form and context in which it appears.

Contact Information

Stephen Baghdadi
Managing Director
Dateline Resources Limited
+61 2 9375 2353
info@datelineresources.com.au
www.datelineresources.com.au

Andrew Rowell
White Noise Communications
+61 400 466 226
andrew@whitenoisecomms.com

Follow Dateline on X: @Dateline_DTR

Dateline Resources Limited
Level 29, 2 Chifley Square, Sydney, NSW 2000, Australia

This press release is authorized for release by the Board of Dateline Resources Limited. and Development

SOURCE: Dateline Resources Limited

View the original press release on ACCESS Newswire

AstroNova breached confidentiality, misrepresented private negotiations

Company demanded silence in exchange for no Board seats, no leadership change, and no path to value creation

Board continues to prioritize entrenchment over addressing shareholder concerns

FORT WORTH, TX / ACCESS Newswire / June 24, 2025 / Dear AstroNova Shareholders,

Yesterday evening, we thought we were participating in confidential negotiations with AstroNova aimed at reaching a collaborative solution to the ongoing proxy contest. This morning, AstroNova blindsided us with a news release publicly mischaracterizing those talks, thereby violating our agreement to keep our discussions private, and severely undermining the prospect of continued engagement. We already knew that AstroNova’s Board could not be trusted to deliver shareholder value; now we know they cannot be trusted to keep their word.

Breach of Trust

Sadly, we must also now share revealing details from an exchange that we were promised would remain private. Following a call with Mr. Warzala last week, we invited the company to propose a solution. Mr. Warzala sent an egregiously one-sided proposal that would entrench the current Board while silencing our ability to advocate for shareholders. The company proposed we sign a standstill agreement in exchange for:

1. No Board representation

2. Mr. Woods leaving the Board but remaining CEO

3. Askeladden attending a single Board meeting as an observer, with no voting rights

No sane professional investor would agree to such terms. They would restrict our ability to trade or speak freely, yet offer no corresponding ability to influence company decisions. The Board wanted our silence – not our input.

We told Mr. Warzala that we remained “happy to further discuss these topics” and “hope we can continue to have mutually beneficial dialogue,” but warned that “in the absence of a proposal that demonstrates the Board is committed to making […] substantial changes […] we’d much rather let shareholders decide who best represents their interests.” We also reiterated concrete steps that could safeguard shareholder interests, such as hiring a proven print industry executive or initiating a strategic alternatives process, yet Mr. Warzala showed no interest in exploring these ideas.

We intended to respond to Mr. Warzala’s latest email this morning. Instead, the company rushed to issue a news release – shutting off dialogue before we even had a chance to reply in detail. AstroNova abandoned any effort to engage when we provided candid feedback on the inadequacy of their initial proposal. Once again, the company seems more concerned with scoring PR points than with resolving shareholder concerns. This mirrors their prior conduct – demanding a call on an hour’s notice after months of ignoring us, then claiming we were reluctant to engage.

Other contradictions

The company’s press release is rife with other contradictions. The Board now claims it “shares many of Samir Patel’s concerns” and “began actively addressing many of these issues long before Samir commenced his proxy contest.” Yet in a letter two weeks ago, the company impugned my supposed “readily apparent […] lack of knowledge and understanding of AstroNova’s business.” Which version should shareholders believe – what the Board says today, or what they said two weeks ago?

Similarly, Mr. Warzala’s reference to a “takeover” is disingenuous. One of our publicly-stated priorities is to evaluate strategic alternatives to determine if substantially higher value could be achieved for all shareholders in private markets, yet the company has publicly dismissed this idea as unworthy of consideration. Finally, the Board claims it is “on track” to achieve a share price equivalent to the pre-pandemic peak – despite FY25 earnings results and FY26 earnings guidance that remain below FY24 levels.

After presiding over the MTEX disaster and the ensuing ~50% decline in shareholder value, the incumbent Board refuses to consider meaningful change – whether replacing the CEO, refreshing the Board, or exploring a sale. Their priorities are clear: maintaining control matters more than delivering results and restoring shareholder value.

We urge shareholders to vote to elect directors who truly care about rapidly maximizing shareholder value. If you need assistance in voting the GOLD proxy card, please contact InvestorCom at (877) 972-0090. If you would like to speak to me or any of our candidates, please don’t hesitate to contact me directly.

Sincerely,

Samir Patel
samir@askeladdencapital.com
(682) 553-8302

This filing, and future filings, will also be made available to shareholders after dissemination on EDGAR via our website: https://www.askeladdencapital.com/astronova/ These documents will also be available at no cost at www.sec.gov.

Samir Patel, Askeladden Capital Management LLC, Jeff Sands, Shawn Kravetz, Ryan Oviatt and Boyd Roberts (collectively the “Participants”) filed a definitive proxy statement and accompanying proxy card with the SEC on May 20, 2025, as amended on May 21, 2025, to be used in soliciting proxies in connection with the 2025 annual meeting of shareholders (the “Annual Meeting”) of AstroNova, Inc. (the “Company”). All shareholders of the Company are advised to read the Proxy Statement and other documents related to the solicitation of proxies, each in connection with the Annual Meeting, by the Participants, as they contain important information, including additional information related to the Participants, including a description of their direct or indirect interests by security holdings or otherwise. The Proxy Statement and an accompanying GOLD proxy card will be furnished to some or all of the Company’s stockholders and is, along with other relevant documents, available at no charge on the SEC website at http://www.sec.gov, or by contacting Samir Patel at 1452 Hughes Road, Suite 200 #582, Grapevine, TX, 76051.

SOURCE: Askeladden Capital Management LLC

View the original press release on ACCESS Newswire